Lía-Crosa V, Aquieri A, Pineda V, Fernandez D, Volberg V, Rubilar B

Idioma: Inglés [English version]
Referencias bibliográficas: 17
Paginas: s434-438
Archivo PDF: 205.49 Kb.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Slomski A. Why do hundreds of US women die annually in childbirth? JAMA 2019; 321 (13): 1239-1241.

2. Donati S, Maraschini A, Dell'Oro S, Lega I, D'Aloja P. The way to move beyond the numbers: the lesson learnt from the Italian obstetric surveillance system. Ann Ist Super Sanita. 2019; 55 (4): 363-370.

3. Lima FV, Yang J, Xu J, Stergiopoulos K. National trends and in-hospital outcomes in pregnant women with heart disease in the United States. Am J Cardiol. 2017; 119 (10): 1694-1700.

4. World Health Organization. Available in: https://www.who.int/es/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis 27/4/2019.

5. Kampman MA, Valente MA, van Melle JP, Balci A, Roos-Hesselink JW, Mulder BJ et al. Cardiac adaption during pregnancy in women with congenital heart disease and healthy women. Heart. 2016; 102: 1302-1308.

6. Cornette J, Ruys TP, Rossi A, Rizopoulos D, Takkenberg JJ, Karamermer Y et al. Hemodynamic adaptation to pregnancy in women with structural heart disease. Int J Cardiol. 2013; 168: 825-831.

7. Roos-Hesselink JW, Budts W, Walker F, De Backer JFA, Swan L, Stones W et al. Organisation of care for pregnancy in patients with congenital heart disease. Heart. 2017; 103: 1854-1859.

8. Damman K, Valente MA, Voors AA, O´Connor CM, Van Veldhuisen DJ, Hillege HL. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J. 2014; 35 (7): 455-469.

9. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006; 367: 1066-1074.

10. Pijuan-Domènech A, Galian L, Goya M, Casellas M, Merced C, Ferreira-Gonzalez I et al. Cardiac complications during pregnancy are better predicted with the modified who risk score. Int J Cardiol. 2015; 195: 149-154.

11. Tanous D, Siu SC, Mason J, Greutmann M, Wald RM, Parker JD et al. B-type natriuretic peptide in pregnant women with heart disease. J Am Coll Cardiol. 2010; 56: 1247-1253.

12. Kampman MA, Balci A, van Veldhuisen DJ, van Dijk AP, Roos-Hesselink JW, Sollie-Szarynska KM et al. N-terminal pro-b-type natriuretic peptide predicts cardiovascular complications in pregnant women with congenital heart disease. Eur Heart J. 2014; 35: 708-715.

13. Del Sueldo MA, Mendonca RMA, Sánchez-Zambrano MB, Zilberman J, Múnera-Echeverri AG, Paniagua M et al. Guía de práctica clínica de la Sociedad Interamericana de Cardiología sobre prevención primaria de enfermedad cardiovascular en la mujer. Arch Cardiol Méx. 2022; 92 (Supl. 2): 1-68.

14. Wang MC, Freaney PM, Perak AM, Allen NB, Greenland P, Grobman WA et al. Association of pre-pregnancy cardiovascular risk factor burden with adverse maternal and offspring outcomes. Eur J Prev Cardiol. 2022; 29: e156-e158.

15. Liu H, Huang TT, Lin JH. Risk factors and risk index of cardiac events in pregnant women with heart disease. Chin Med J (Engl). 2012; 125: 3410-3415.

16. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomstrom-Lundqvist C, Cífková R, De Bonis M et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018; 39 (34): 3165-3241.

17. Benassi MD, Avayú DH, Tomasella MP, Valera ED, Pesce R, Lynch S, et al. Consenso enfermedad de Chagas 2019. Rev Argent Cardiol. 2020; 88 (Supl. 8): 1-74.